Yuyoung Ceftriaxone Sodium Hydrate Injection 1 Gram

Adult administration

For adults and children over 12 years old, administer 1-2g (potency) of ceftriaxone once daily via intravenous or intramuscular injection. For infections caused by pathogens with severe or moderate susceptibility, the dose may be increased to 4g (potency) once daily. Elderly patients can follow the adult dosage without modification.

Child administration

For neonates (within 14 days of birth), administer 20-50mg (potency) per kg body weight once daily, not exceeding 50mg (potency) per kg body weight. For infants and children (from 15 days to 12 years), weight

This medication should not be mixed or administered simultaneously with calcium-containing solutions. Especially in newborns under 28 days old, the combined use with calcium-containing solutions may cause serious precipitates and be hazardous, so it should never be used. Patients with an allergy to this medication or who have had hypersensitivity reactions to cephalosporins or penicillin antibiotics should not use it. Furthermore, it is not administered to premature infants or newborns with issues in bilirubin metabolism as it can increase the risk of bilirubin encephalopathy. Patients with severely impaired kidney function or allergic individuals should use this medication cautiously, and dosage or administration interval adjustments may be necessary. This medication can cause various side effects such as diarrhea, rash, liver function abnormalities, blood cell count changes, and if any unusual symptoms arise during administration, medical personnel should be notified immediately. Hypersensitivity or shock symptoms may occur, hence thorough questioning and observation before administration are essential, and emergency preparedness is necessary. Regular liver and kidney function tests are important when using this medication long-term or in high doses. The safety during pregnancy has not been fully confirmed, so women who are pregnant or may become pregnant should consult a doctor before use. Caution is also needed as some of this medication may be excreted in breast milk. Dizziness and similar side effects may occur while driving or operating machinery, hence care should be taken. There may be drug interactions, especially with diuretics, aminoglycoside antibiotics, and vitamin K antagonists, so notify healthcare providers when taking these medications together. When administering, a different infusion port must be used from calcium-containing solutions, and the infusion line must be cleaned thoroughly before and after infusion. After preparation, it should be used as soon as possible and stored according to the specified temperature and duration.

Serious side effects

Hives, severe swelling (edema), cold sweat, pallor, high fever with severe rash, blisters, skin peeling, oral/ocular mucosal pain, difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), severe lethargy, sudden and very severe headache, lightning headache, seizures, confusion, visual disturbances, paralysis, significantly reduced urine output, severe swelling throughout the body,

Mild side effects

• Eosinophilia
• leukopenia
• thrombocytopenia
• diarrhea
• rash
• elevated liver enzymes
• headache
• dizziness
• bronchospasm
• loose stools

This medication should be stored in a sealed container to prevent air or moisture from entering, preferably at room temperature between 1 to 30 degrees Celsius. Storing it this way will maintain the medication's efficacy and prevent degradation.

Appearance

Brown or transparent vial containing a white or light yellow powder

Package unit

10 vials